e6742
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 2, 2017 (NCT03082235)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Toll-like receptor 8ANTAGONIST
TLR8 antagonist
- Toll-like receptor 7ANTAGONIST
TLR7 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e6742
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05278663 | Phase 1/Phase 2 (Phase 2) | Apr 14, 2022 | Eisai |
| NCT04683185 | Phase 1 | Jan 12, 2021 | Eisai |
| NCT03082235 | Phase 1 | Mar 2, 2017 | Eisai |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 3 | 3 | 2 | 2017 |
1 organizations
Page 1 / 1